Filing Flows › Kinross Gold (KGC) › Stock forecast & fair value
Kinross Gold (KGC) stock forecast and fair value
Kinross Gold (KGC) trades at $22.34. 10 analysts' median price target is $33.00 (+48%), from $10.00 to $39.00. Across 11 valuation methods the middle fair value is $31.07 (+39%); the DCF says $29.45.
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| DCF — Monte Carlo 10th–90th percentile | $20.73 | $29.45 | $40.68 | +32% |
| P/E vs peers | $29.16 | $33.66 | $72.42 | +51% |
| EV/EBITDA vs peers | $40.13 | $43.32 | $76.02 | +94% |
| EV/Sales vs peers | $23.92 | $29.97 | $79.36 | +34% |
| Analysts' price targets | $10.00 | $31.07 | $39.00 | +39% |
| Outside view — base-rate Monte Carlo | −$19.70 | $37.54 | $223.05 | +68% |
| Owner earnings capitalized | $25.99 | $29.80 | $34.92 | +33% |
| Stage-weighted value (cyclical) | $40.13 | $43.32 | $76.02 | +94% |
| Graham formula (revised) | $31.62 | $40.36 | $49.10 | +81% |
| Lynch fair P/E (PEGY) | $10.29 | $19.78 | $30.08 | -11% |
Kinross Gold's latest quarter
Kinross Gold, FY2025: revenue $7.1B (+37% year over year), operating margin 46.5%, net earnings $2.4B, operating cash flow $3.8B. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for KGC stock?
The median of 10 analysts' 12-month targets is $33.00, +48% from $22.34; the range is $10.00 to $39.00. The average rating is buy.
What is Kinross Gold's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $19.78 and $43.32, with a middle value of $31.07 against a price of $22.34. Each method's assumptions are on the page.
Does Kinross Gold usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is KGC stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.